Analysis of SUSD2 expression across various types of cancer revealed significant upregulation of SUSD2 in bladder urothelial carcinoma, breast invasive carcinoma, cholangiocarcinoma, head and neck squamous cell carcinoma, liver hepatocellular carcinoma, and thyroid carcinoma. Here, SUSD2 is linked to cholangiocarcinoma.